摘要
目的:观察原发性高血压患者分别服用噻嗪类利尿剂、氯沙坦4周后血清尿酸的变化。方法:对在我院连续诊疗的原发性高血压患者128例随机分为利尿剂组和氯沙坦组,利尿剂组63例,氯沙坦组65例。结果:两组药物均能明显降低患者的血压,且两组降压幅度无明显差异。利尿剂组治疗后尿酸平均升高41.67μmol/L(P<0.01),氯沙坦组平均下降30.47μmol/L(P<0.01),两组药物治疗后尿酸之间的差异有显著性。结论:噻嗪类利尿剂会升高原发性高血压病患者尿酸水平,氯沙坦可降低原发性高血压患者的尿酸水平。
Objective :To survey the serum uric acid changes after 4-week antihypertensive treatment with thiazide diuretics,losartan in the patients with essential hypertension. Methods:A total of 128 consecutive patients with essential hypertension were allocated randoraly to diuretics group (n=63), losartan group (n=65). The blood pressure and serum uric acid,before and after antihypertensive treatments,were obtained in all patients. Results :Two groups,diuretics group and losartan group,could significantly lower blood pressure, and the range of lowering blood pressure had no significant difference. Serum uric acid was significantly increased (41.67 umol/L) in diuretics group(P〈0.01),but significantly reduced (30.47 umol/L) in losartan group(P〈0.01). Conclusion:The thiazide diuretics could further aggravate hyperurieaciduria while losartan could reduce hypemfieaeiduria in the patients with essential hypertension.
出处
《现代医药卫生》
2009年第12期1771-1772,共2页
Journal of Modern Medicine & Health